Haemonetics Corp (HAE)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$68.86

Buy

$69.18

arrow-down$-1.36 (-1.94%)

Prices updated at 13 May 2025, 15:48 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.
S&P 500
arrow-up0.6%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Ms. Ellen M. Zane
CEO
Mr. Christopher A. Simon
Most recent earnings
31 Mar 2024
Fiscal year end
31 Mar 2024
Employees
3,657
Head office
125 Summer Street
Boston
United States
02110
mobile
+1 781 848-7100
letter
olga.guyette@haemonetics.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Josep L. Llorens
Executive Vice President, Global Manufacturing and Supply Chain
0.49m
Mr. Roy Galvin
Executive Vice President and Chief Commercial Officer
-
Mr. Frank W. Chan
Executive Vice President and Chief Operating Officer
-
Mr. Charles J. Dockendorff
Independent Director
0.10m
Ms. Ellen M. Zane
Chairman of the Board
0.25m
Mr. Michael J. Coyle
Independent Director
0.08m
Dr. Mark W. Kroll,PhD,F.A.C.C.,F.H.R.S.
Independent Director
0.08m
Mr. Robert E. Abernathy
Independent Director
0.10m
Mr. Stewart W. Strong
President, Global Hospital
-
Ms. Diane M. Bryant
Independent Director
0.05m
Dr. Claire Pomeroy, M.B.A.,M.D.
Independent Director
0.09m
Mr. Christopher A. Simon
Director, President and Chief Executive Officer
1.09m
Ms. Michelle L. Basil
Executive Vice President and General Counsel
0.52m
Mr. Lloyd E. Johnson
Independent Director
0.08m
Ms. Laurie A. Miller
Senior Vice President and Chief Human Resources Officer
-
Mr. James C. D’Arecca
Executive Vice President and Chief Financial Officer
0.55m
Ms. Maryanne Maunsell Farris
Vice President and Chief Accounting Officer
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
BlackRock Inc6,159,904
Vanguard Group Inc5,179,388
Neuberger Berman Investment Advisers LLC4,419,343
Neuberger Berman Group LLC4,419,343
Capital Research Global Investors4,238,954

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
01 Nov 2024-
17 Sep 2024-
29 Aug 2024-
26 Jul 2024-
25 Jul 2024-
25 Jul 2024-
25 Jul 2024-
25 Jul 2024-
25 Jul 2024-
25 Jul 2024-
25 Jul 2024-
25 Jul 2024-
24 Jul 2024-
25 Jul 2024-
12 Jul 2024-
11 Jul 2024-
06 Jun 2024-
06 Jun 2024-
06 Jun 2024-
28 May 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.